biocon

Biocon Q4 FY17 Revenue Rs 974 Cr; Net Profit Rs 127 Cr; FY17 Revenue...

Biocon Q4 FY17 Revenue Rs 974 Cr; Net Profit Rs 127 Cr; FY17 Revenue at Rs 4,079 Cr; Net Profit at Rs 612 Cr Board of Directors Recommends 2:1 Bonus Shares  Bengaluru, Karnataka, India: April 27, 2017/ Biocon...
imcyse

Imcyse obtains authorization to launch Phase 1b trial in Type 1 diabetes

Liège, Belgium, May 30, 2017 – Imcyse, who develop active specific therapies for the treatment and prevention of severe chronic diseases, today announces that the Belgian and British regulatory authorities have authorized the launch...

Healthcare movers to watch – Amicus Therapeutics, Inc., Infinity Pharmaceuticals Inc.

Wall Street stocks were trading modestly lower Monday as the main indexes pulled back amid mixed earnings. The Dow Jones Industrial Average DJIA, -0.06%  was hovering around break-even levels at 20.061. The blue-chip index was...
novartis pharmaceutical

T-Hub teams up with Novartis Healthcare to help health tech start-ups

Start-up engine, T-Hub, has signed a Memorandum of Understanding (MoU) with pharmaceutical major Novartis Healthcare Private Ltd (NHPL) to create and execute joint programmes to help health tech start-ups from across segments. As part of...
Dishman Pharma

Dishman Pharma Shares Surge 8.5%

New Delhi: Shares of Dishman Pharmaceuticals continued to surge for the second trading session and rose by 8.5% on Wednesday, after the company’s partner Tesaro got the US FDA’s approval for an ovarian cancer...
Glenmark

Glenmark Gets USFDA Nod For Anti-Cholesterol Drug

Drug firm Glenmark Pharmaceuticals today said it has received final approval from the USFDA for its generic version of Fenofibrate capsules used for lowering cholesterol. The company has been granted final approval by the United...

Consumers most worried about healthcare according to new survey

Healthcare costs are consumers' biggest worry, and just half have confidence in the healthcare system according to a recent survey. Consumer's latest survey focuses on the cost of living, and 68 per cent of...
Hitgen and Cancer Research UK’s Manchester Institute enter licence agreement in lung cancer

Hitgen And Cancer Research Uk’s Manchester Institute Enter Licence Agreement In Lung Cancer

Cancer Research UK, Cancer Research Technology (CRT), the charity’s commercial arm, and HitGen Ltd, a privately held biotech company focused on early drug discovery, announced today that they have entered into a licence agreement...

APEC Digital Hub welcomes recommendations to grow health care sector in innovative ways

The APEC Digital Hub for Mental Health welcomes the Advisory Council on Economic Growth's recommendation to help grow "high potential sectors" in Canada, including health care, in innovative ways in its report, The Path...

CitiusTech ties up with Tata Memorial Hospital for paediatric cancer care

CitiusTech has entered into an agreement with Tata Memorial Hospital and extended its support for the use of Percutaneous Intravenous Central Catheters (PICC lines) amongst children suffering from cancer. This will eliminate the need...